SignatureFD’s Inhibrx, Inc. Common Stock INBX Stock Holding History

SignatureFD’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-758	Closed	-$26.5K	–	3309
2024 Q1	$26.5K	Hold	758	–	–	﹤0.01%	1860
2023 Q4	$28.8K	Buy	758 +742	+4,638%	+$15.9K	﹤0.01%	1739
2023 Q3	$294	Sell	16 -115	-88%	-$2.41K	﹤0.01%	3067
2023 Q2	$3.4K	Buy	131 +115	+719%	+$2.69K	﹤0.01%	2640
2023 Q1	$302	Hold	16	–	–	﹤0.01%	3148
2022 Q4	$394	Hold	16	–	–	﹤0.01%	3131
2022 Q3	$0	Buy	+16	New	+$288	﹤0.01%	3483
2022 Q2	–	Sell	-85	Closed	-$2K	–	3469
2022 Q1	$2K	Buy	85 +16	+23%	+$408	﹤0.01%	2923
2021 Q4	$3K	Buy	69 +47	+214%	+$1.88K	﹤0.01%	2658
2021 Q3	$1K	Buy	+22	New	+$669	﹤0.01%	3013

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SignatureFD's INBX Position: Q2 2024 in Review

SignatureFD sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 758 shares — an estimated $26.5K sold.

SignatureFD first reported a position in INBX in Q3 2021 and held it in 10 quarters. The position peaked at $28.8K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

SignatureFD reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
SignatureFD sold 758 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $26.5K.
SignatureFD first reported a position in Inhibrx, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
SignatureFD's Inhibrx, Inc. Common Stock position peaked at $28.8K in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on SignatureFD's 13F filing for Q2 2024, filed 29 Jul 2024.